All lobbying filings

THE MCMANUS GROUP

Lobbying for ZIMMER BIOMET · A global leader in musculoskeletal healthcare.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 4

HR 3006
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an am…
S 1776
Medicare Beneficiary Co-Pay Fairness Act
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 2

Medicare/Medicaid

Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)

Health Issues

Issues related to Artificial Intelligences approval in Medical Devices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.